CCS
ZBH icon

Concentric Capital Strategies’s Zimmer Biomet ZBH Stock Holding History

Concentric Capital Strategies’s Portfolio ZBH Stock Details ZBH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-18,759
Closed -$1.96M – 222
2022
Q3 		$1.96M Buy
+18,759
New +$2.06M 0.69% 53
2022
Q2 		– Sell
-6,600
Closed -$844K – 181
2022
Q1 		$844K Buy
+6,600
New +$796K 0.28% 108

Other funds holding ZBH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Concentric Capital Strategies's ZBH Position: Q4 2022 in Review

Concentric Capital Strategies sold out of Zimmer Biomet (ZBH) in Q4 2022, closing a stake of 18,759 shares — an estimated $1.96M sold.

Concentric Capital Strategies first reported a position in ZBH in Q1 2022 and held it in 2 quarters. The position peaked at $1.96M in Q3 2022. 977 funds tracked by Wall St. Rank hold ZBH as of Q4 2022.

  • Concentric Capital Strategies reported no remaining Zimmer Biomet position as of Q4 2022 after selling out during the quarter.
  • Concentric Capital Strategies sold 18,759 Zimmer Biomet shares in Q4 2022, an estimated $1.96M.
  • Concentric Capital Strategies first reported a position in Zimmer Biomet in Q1 2022 and held it in 2 quarters.
  • Concentric Capital Strategies's Zimmer Biomet position peaked at $1.96M in Q3 2022.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2022.

Based on Concentric Capital Strategies's 13F filing for Q4 2022, filed 14 Feb 2023.